Evaluating revefenacin as a therapeutic option for chronic obstructive pulmonary disease

Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials

(2019) James F. Donohue et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease

(2019) James F. Donohue et al.   RESPIRATORY MEDICINE

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study

(2019) Marie T. Borin et al.   Clinical Pharmacology in Drug Development

Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function

(2019) Marie T Borin et al.   International Journal of Chronic Obstructive Pulmonary Disease

Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies

(2018) Dean Quinn et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of aclidinium/formoterolversussalmeterol/fluticasone: a phase 3 COPD study

(2016) Claus Vogelmeier et al.   EUROPEAN RESPIRATORY JOURNAL

Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses

(2016) Donald P. Tashkin et al.   RESPIRATORY MEDICINE

Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

(2015) Nicola Scichilone et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

(2008) Donald P. Tashkin et al.   NEW ENGLAND JOURNAL OF MEDICINE